JNK1 (MAPK8)

MAPK8 (JNK1) Gene

Introduction

Jnk1 (Mapk8) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MAPK8 (JNK1) Gene

Introduction

Jnk1 (Mapk8) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MAPK8 (Mitogen-Activated Protein Kinase 8), also known as JNK1 (c-Jun N-terminal Kinase 1), is a critical stress-activated protein kinase that plays dual roles in neuronal survival and death. As part of the MAPK family, JNK1 is activated by various cellular stresses including oxidative stress, neuroinflammation, excitotoxicity, and protein aggregation. Dysregulation of JNK1 signaling is implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), stroke, and traumatic brain injury. The kinase phosphorylates numerous transcription factors and structural proteins, making it a central regulator of stress response pathways in [neurons](/entities/neurons) [1][2]. [@manning2003]

<div class="infobox infobox-gene"> [@pocivavsek2021]

| Property | Value | [@yun2020]
|----------|-------| [@zhang2019]
| Gene Symbol | MAPK8 | [@chambers2023]
| Alias | JNK1, SAPK1 | [@ferrante2020]
| Full Name | Mitogen-Activated Protein Kinase 8 | [@borsello2003]
| Chromosomal Location | 10q11.22 | [@kuan2022]
| NCBI Gene ID | 5599 | [@coffey2021]
| OMIM ID | 601158 |
| Ensembl ID | ENSG00000107643 |
| UniProt ID | P45985 |
| Encoded Protein | JNK1 (464 amino acids) |
| Protein Family | MAPK family, JNK subfamily |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Stroke, TBI |

</div>

Molecular Biology

Gene Structure

The MAPK8 gene spans approximately 35 kb and consists of 12 exons. It encodes three alternatively spliced isoforms:

• JNK1α1 (46 kDa): Predominant neuronal isoform
• JNK1α2 (45 kDa): Alternative splicing variant
• JNK1β: Less characterized isoform

Protein Structure

JNK1 is a serine/threonine protein kinase with characteristic kinase domain architecture:

Domains:

• ATP-binding pocket
• Activation loop (Thr183, Tyr185)
• Substrate recognition site

• Recognition by E3 ubiquitin ligases
• Regulates protein stability

• Docking sites for substrates
• Interaction with scaffolding proteins

Isoforms and Variants

JNK1 Isoforms:

• JNK1α1/α2: Neuron-enriched
• JNK1β1/β2: Less neuron-specific

• rs12720356: Associated with PD risk
• rs1063843: Affects kinase activity
• rs3821952: Linked to AD susceptibility

Signal Transduction Pathways

JNK Activation Cascade

JNK1 activation follows the canonical MAP kinase cascade:

Upstream Activation:

• MEKK1, MEKK4, MLK3, TAK1
• Activated by cytokines, stress

• Dual-specificity kinases
• Phosphorylate JNK on Thr183/Tyr185

• Active JNK translocates to nucleus
• Phosphorylates substrates

JNK1 Activation Mechanisms

Stress-Activated Pathways:

• Oxidative Stress: [ROS](/entities/reactive-oxygen-species) activates ASK1/MEKK1
• DNA Damage: ATM/ATR activate MLK3
• Excitotoxicity: Glutamate activates mGluR5/AMPAR
• TNF-α Signaling: TRADD/TRAF2 activate MEKK1
• Endoplasmic Reticulum Stress: IRE1 activates ASK1

• MKP1, MKP5 dephosphorylate JNK
• JIP scaffold proteins organize signaling
• [Autophagy](/entities/autophagy) degrades activated JNK

Cellular Functions

Transcriptional Regulation

JNK1 phosphorylates numerous transcription factors:

AP-1 Family:

• c-Jun: Primary substrate, forms AP-1 complexes
• JunD: Neuronal survival regulation
• ATF2: Stress gene activation

• p53: Pro-apoptotic signaling
• NFAT: Calcium-dependent transcription
• HIF-1α: Hypoxia response

Neuronal Functions

Synaptic Plasticity:

• Regulates AMPA receptor trafficking
• Modulates [NMDA receptor](/entities/nmda-receptor) function
• Controls [LTP](/mechanisms/long-term-potentiation) and LTD
• Essential for memory consolidation

• Regulates cytoskeletal dynamics
• Affects growth cone collapse
• Guides neuronal connectivity

• Controls dendritic branching
• Regulates spine morphology
• Modulates synaptic strength

Stress Response

Pro-survival vs Pro-death:

• Acute, transient activation: protective
• Chronic, sustained activation: apoptotic
• Cell type and context dependent

Brain Expression and Localization

Regional Distribution

High Expression:

• [Hippocampus](/brain-regions/hippocampus) (CA1-CA3, dentate gyrus)
• Cerebral [cortex](/brain-regions/cortex) (layers II-VI)
• Cerebellum (Purkinje cells)
• Basal ganglia (striatum, substantia nigra)
• [Amygdala](/brain-regions/amygdala)
• [Hypothalamus](/brain-regions/hypothalamus)

• Cytoplasmic (resting state)
• Nuclear (upon activation)
• Mitochondrial (during apoptosis)
• Synaptic (activity-dependent)

Cell-Type Specificity

• Pyramidal neurons (excitatory)
• Dopaminergic neurons
• GABAergic interneurons
• [Astrocytes](/entities/astrocytes)
• [Microglia](/cell-types/microglia-neuroinflammation)

Disease Associations

Alzheimer's Disease (AD)

JNK1 is chronically hyperactivated in AD brain and represents a critical pathological mechanism [3][4]:

Evidence:

• JNK1/2/3 elevated in AD hippocampus (3-5 fold)
• Activated JNK co-localizes with NFTs
• JNK1/2 in amyloid plaques
• p-c-Jun in vulnerable neurons

• JNK phosphorylates tau at Thr181, Ser202, Thr205, Ser396
• Activates [GSK-3β](/entities/gsk3-beta)
• Inhibits [PP2A](/entities/pp2a)
• Promotes NFT formation

• [Aβ](/proteins/amyloid-beta) activates JNK pathway
• JNK mediates Aβ-induced [apoptosis](/entities/apoptosis)
• Synaptic dysfunction through JNK
• Memory impairment

• Impairs LTP
• Reduces spine density
• Alters glutamate signaling
• Causes synaptic loss

• Activates microglia
• Increases IL-1β, TNF-α
• Chronic neuroinflammation
• Glial activation loop

Parkinson's Disease (PD)

JNK1 contributes to dopaminergic neuron death in PD [5][6]:

Evidence:

• JNK activated in PD substantia nigra
• Elevated p-c-Jun in surviving neurons
• Postmortem studies confirm activation

• Mitochondrial toxins activate JNK
• 6-OHDA, MPTP models
• ROS-JNK-apoptosis cascade

• Oligomeric α-syn activates JNK
• JNK in Lewy bodies
• Contributes to neurodegeneration

• JNK in SNc neurons
• Metabolic stress sensitivity
• Apoptotic pathway activation

• MPPT activates JNK pathway
• Neuroprotection with JNK inhibitors
• Therapeutic proof-of-concept

Huntington's Disease (HD)

JNK1 dysregulation in HD [7]:

Evidence:

• Elevated JNK activity in HD brain
• Mutant [huntingtin](/proteins/huntingtin) activates JNK
• Phosphorylated c-Jun in striatum

• Mutant Htt activates ASK1-JNK
• Transcriptional dysregulation
• Mitochondrial dysfunction
• Excitotoxicity amplification

Stroke and Brain Ischemia

JNK1 is a major contributor to ischemic brain injury:

Mechanisms:

• Rapid activation (minutes)
• Excitotoxicity amplifies JNK
• [Blood-brain barrier](/entities/blood-brain-barrier) disruption
• Infarct expansion

• JNK inhibitors neuroprotective
• TAT-JNKi (cell-permeable)
• SP600125 in animal models

Traumatic Brain Injury (TBI)

• JNK activated post-TBI
• Contributes to secondary injury
• Chronic activation in CTE
• Therapeutic target

Animal Models

Knockout Mice

Jnk1-/- Mice:

• Viable with mild phenotypes
• Reduced stress-induced apoptosis
• Defects in LTP
• Learning impairments

• JNK3: neuronal isoform knockout
• Protected from MPTP
• Reduced infarct size
• Behavioral improvements

Transgenic Models

Neuron-specific JNK1 overexpression:

• Spontaneous neurodegeneration
• Synaptic loss
• Cognitive deficits
• Used for drug testing

• Neuroprotection
• Improved function
• Therapeutic proof-of-concept

Therapeutic Targeting

JNK Inhibitors

Small Molecule Inhibitors:

• First-generation JNK inhibitor
• Broad specificity
• Used in research

• Covalent inhibitor
• High potency
• In clinical trials for cancer

• GADD45β modulator
• Reduces JNK activation
• In development

• CNS-penetrant
• Neuroprotective in models
• Preclinical

• Cell-permeable peptide
• Blocks JNK interaction
• Neuroprotective

• Scaffold-based inhibition
• Substrate-specific

• JNK inhibition
• Anti-inflammatory
• AD/PD therapeutic

• SIRT1 activation
• JNK inhibition

• AMPK activation
• JNK inhibition

Clinical Trials

• NCT05678933: JNK inhibitor in AD (planned)
• NCT05456794: Neuroprotection in PD
• NCT05320116: Stroke intervention

Biomarkers

JNK Activity Markers

Phospho-JNK Detection:

• Western blot (p-JNK)
• ELISA for p-JNK
• Immunohistochemistry
• CSF p-JNK levels

• c-Jun phosphorylation
• ATF2 activation
• GADD45 expression

Clinical Assessment

• CSF biomarkers (research)
• PET ligands (in development)
• Functional outcomes

Research Directions

Current Focus Areas

• JNK1 vs JNK2 vs JNK3
• Tissue-specific targeting
• Reduced side effects

• Overcoming BBB
• Sustained delivery
• Optimal pharmacokinetics

• JNK + amyloid targeting
• Multi-pathway modulation
• Synergistic effects

• Patient selection
• Treatment response
• Dose optimization

Challenges

• JNK has both protective and harmful functions
• Chronic inhibition may have side effects
• Isoform specificity is critical
• Delivery to neurons

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease) - Alzheimer's Disease
• [Parkinson's Disease](/diseases/parkinsons-disease) - Parkinson's Disease
• [/diseases/huntingtons-disease](/diseases/huntingtons) - Huntington's Disease
• [/proteins/jnk1-protein](/proteins/jnk1-protein) - JNK1 Protein
• [/proteins/mapk8-protein](/proteins/mapk8-protein) - MAPK8 Protein
• [/mechanisms/oxidative-stress](/mechanisms/oxidative-stress) - Oxidative Stress
• [/mechanisms/excitotoxicity](/mechanisms/excitotoxicity) - Excitotoxicity
• [Neuroinflammation](/mechanisms/neuroinflammation) - Neuroinflammation

Background

The study of Jnk1 (Mapk8) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Pathway Diagram

The following diagram shows the key molecular relationships involving JNK1 (MAPK8) discovered through SciDEX knowledge graph analysis: